Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.

Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL, Faucett C, Fletcher MA, Kleinman SH, Operskalski EA, et al.

Ann Intern Med. 1990 Nov 15;113(10):733-9.

PMID:
2240875
2.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
3.

Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.

Wannamethee SG, Sirivichayakul S, Phillips AN, Ubolyam S, Ruxrungtham K, Hanvanich M, Phanuphak P.

Int J Epidemiol. 1998 Apr;27(2):289-95.

PMID:
9602412
4.

Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group.

Busch MP, Operskalski EA, Mosley JW, Stevens CE, Schiff ER, Kleinman SH, Lee H, Lee M, Harris M.

Transfusion. 1994 Oct;34(10):858-64.

PMID:
7940656
5.

Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group.

Fletcher MA, Mosley JW, Hassett J, Gjerset GF, Kaplan J, Parker JW, Donegan E, Lusher JM, Lee H.

Blood. 1992 Aug 1;80(3):831-40.

6.

Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group.

Lang DJ, Kovacs AA, Zaia JA, Doelkin G, Niland JC, Aledort L, Azen SP, Fletcher MA, Gauderman J, Gjerset GJ, et al.

J Acquir Immune Defic Syndr. 1989;2(6):540-9.

PMID:
2555471
7.
8.
9.

A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1.

Hutto C, Parks WP, Lai SH, Mastrucci MT, Mitchell C, Munoz J, Trapido E, Master IM, Scott GB.

J Pediatr. 1991 Mar;118(3):347-53.

PMID:
1671878
10.

[Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].

Vial PA, Ferreccio C, Abarca K, Ortiz E, Noriega M, Pérez C, Labarca J, Torres M, Ferrés M, González C, Acuña G.

Rev Med Chil. 1996 May;124(5):525-35. Spanish.

PMID:
9035503
11.

Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.

Ward JW, Holmberg SD, Allen JR, Cohn DL, Critchley SE, Kleinman SH, Lenes BA, Ravenholt O, Davis JR, Quinn MG, et al.

N Engl J Med. 1988 Feb 25;318(8):473-8.

PMID:
3422337
12.
13.

The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.

Ward JW, Bush TJ, Perkins HA, Lieb LE, Allen JR, Goldfinger D, Samson SM, Pepkowitz SH, Fernando LP, Holland PV, et al.

N Engl J Med. 1989 Oct 5;321(14):947-52.

PMID:
2779617
14.

T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research Network.

Douglas SD, Rudy B, Muenz L, Starr SE, Campbell DE, Wilson C, Holland C, Crowley-Nowick P, Vermund SH.

Arch Pediatr Adolesc Med. 2000 Apr;154(4):375-80.

PMID:
10768676
15.
16.

Human immunodeficiency virus seroprevalence among blood product recipients in San Francisco before transfusion.

Hwang LY, Beasley RP, Busch MP, Lane PK, Vyas GN.

Transfusion. 1989 Feb;29(2):113-8.

PMID:
2919421
17.

Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners.

O'Brien TR, Busch MP, Donegan E, Ward JW, Wong L, Samson SM, Perkins HA, Altman R, Stoneburner RL, Holmberg SD.

J Acquir Immune Defic Syndr. 1994 Jul;7(7):705-10.

PMID:
8207648
18.

Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository.

Kleinman SH, Niland JC, Azen SP, Operskalski EA, Barbosa LH, Chernoff AI, Edwards VM, Lenes BA, Marshall GJ, Nemo GJ, et al.

Transfusion. 1989 Sep;29(7):572-80.

PMID:
2672433
19.

Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.

Touloumi G, Karafoulidou A, Gialeraki A, Katsarou O, Milona I, Kapsimali V, Mandalaki T, Hatzakis A.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):89-97.

PMID:
9732075
20.

Appearance of predictors of disease progression in relation to the development of AIDS.

de Wolf F, Lange JM, Houweling JT, Mulder JW, Beemster J, Schellekens PT, Coutinho RA, van der Noordaa J, Goudsmit J.

AIDS. 1989 Sep;3(9):563-9.

PMID:
2571348

Supplemental Content

Support Center